Advertisement

Health


Biome Australia strikes deal to bring probiotics manufacturing onshore at SPA’s Gold Coast facility

Biome Australia strikes deal to bring probiotics manufacturing onshore at SPA’s Gold Coast facility

Melbourne-based probiotics company Biome Australia (ASX: BIO) has s...

AI-powered biotech startup Gutgutgoose accepted into Silicon Valley's Y Combinator

AI-powered biotech startup Gutgutgoose accepted into Silicon Valley's Y Combinator

Queensland-based biotech startup Gutgutgoose has been accepted into...

4DMedical locks in US radiology deal, European acquisition and clinical program in five-day blitz

4DMedical locks in US radiology deal, European acquisition and clinical program in five-day blitz

Melbourne-based respiratory imaging company 4DMedical (ASX: 4DX) ha...

HealthCo strikes WA Government-backed deal for Healthscope's Mount Private Hospital in Perth

HealthCo strikes WA Government-backed deal for Healthscope's Mount Private Hospital in Perth

HealthCo Healthcare & Wellness REIT (ASX: HCW) has secured a ne...

ANDHealth awards $9m to five digital health startups as sector sounds alarm on capital access

ANDHealth awards $9m to five digital health startups as sector sounds alarm on capital access

Digital health accelerator ANDHealth has awarded up to $9 million i...

Advertisement
Advertisement
Advertisement
Pfizer COVID-19 vaccine now 95 per cent effective

Pfizer COVID-19 vaccine now 95 per cent effective

A COVID-19 vaccine candidate being developed by US pharmaceutical...

Althea gets green light to sell Australian-made medicinal cannabis in Germany

Althea gets green light to sell Australian-made medicinal cannabis in Germany

Melbourne-based Althea Group (ASX: AGH) is on track to becoming t...

Class action "the only hope" for Smiles Inclusive partners on the sidelines

Class action "the only hope" for Smiles Inclusive partners on the sidelines

Smiles Inclusive (ASX: SIL) joint venture partners (JVPs) have ha...

CSL to build $800m flu vaccine facility in Melbourne

CSL to build $800m flu vaccine facility in Melbourne

Australia-headquartered CSL (ASX: CSL) is set to bring a cell-bas...

UQ COVID-19 vaccine "ahead of schedule", Phase 3 trials to commence soon

UQ COVID-19 vaccine "ahead of schedule", Phase 3 trials to commence soon

A COVID-19 vaccine being developed by the University of Queenslan...

Restrictions on ACT venues to ease tomorrow, patron cap will increase to 500

Restrictions on ACT venues to ease tomorrow, patron cap will increase to 500

The improving COVID-19 situation in Victoria and New South Wales ...

Mesoblast rebounds on COVID-19 treatment update, puts vaccine concerns to bed

Mesoblast rebounds on COVID-19 treatment update, puts vaccine concerns to bed

Melbourne-based med-tech company Mesoblast (ASX: MSB) has rebound...

Health fund backs medicinal cannabis with Little Green Pharma deal

Health fund backs medicinal cannabis with Little Green Pharma deal

Little Green Pharma (ASX: LGP) hopes a new strategic partnership ...

Smiles Inclusive enters voluntary administration

Smiles Inclusive enters voluntary administration

The local anaesthetic of turnaround promises has finally wor...

MedAdvisor to buy USA's largest patient-prescriber network Adheris for $49m

MedAdvisor to buy USA's largest patient-prescriber network Adheris for $49m

Medical software group MedAdvisor (ASX: MDR) is prepared to ...

Healthia to buy The Optical Company for $43 million

Healthia to buy The Optical Company for $43 million

Just one day after announcing yet another spending spree, allied ...

Atomo's COVID-19 nasal swab test gets green light from TGA

Atomo's COVID-19 nasal swab test gets green light from TGA

Sydney-based Atomo Diagnostics (ASX: AT1) has yet another feather...

Noxopharm starts trial in COVID-19 treatment race

Noxopharm starts trial in COVID-19 treatment race

Burgeoning medtech company Noxopharm (ASX: NOX) is making strides...

NAB tightens the screws on Smiles Inclusive

NAB tightens the screws on Smiles Inclusive

Smiles Inclusive (ASX: SIL) has been given a slight reprieve on a...

CSL seals deal to supply 51 million doses of UQ COVID-19 vaccine candidate

CSL seals deal to supply 51 million doses of UQ COVID-19 vaccine candidate

Biotechnology giant CSL (ASX: CSL) has finalised an agreement wit...

Advertisement

Partner Content

Introduction: the natural desire to time marketsWhen investors cons...
IntroductionFor decades, term deposits have been a cornerstone of c...
Introduction: A Simple Line With Complex SignalsIn financial market...
Equi Consultancy Partners joined regional leaders at the WEConnect ...
If you run a business website, it’s easy to focus on what custome...
For many Australians, the journey with money begins in a very pract...
Introduction: How Investment Priorities Quietly Change Over TimeInv...
Advertisement